Biocon Management On Q1 Result And Growth Strategy For FY22

Biocon reports 44% contraction in net profit for Q1. What led to a fall in net profit and what's the strategy to fuel growth? In conversation with Executive Chairperson Kiran Mazumdar-Shaw. #Q1WithBQ #BQLive
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.